S124: ADVERSE EVENTS FOLLOWING COVID-19 VACCINATION IN TRANSFUSION-DEPENDENT -THALASSEMIA PATIENTS

Detalles Bibliográficos
Autores principales: Delaporta, P, Kyriakopoulou, D, Ioakeimidou, N, Solomou, E, Binenbaum, I, Toutoudaki, K, Chatzielefteriou, M, Papassotiriou, I, Kattamis, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Oral Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811850/
http://dx.doi.org/10.1097/01.HS9.0000821464.52797.65
_version_ 1784644519890780160
author Delaporta, P
Kyriakopoulou, D
Ioakeimidou, N
Solomou, E
Binenbaum, I
Toutoudaki, K
Chatzielefteriou, M
Papassotiriou, I
Kattamis, A
author_facet Delaporta, P
Kyriakopoulou, D
Ioakeimidou, N
Solomou, E
Binenbaum, I
Toutoudaki, K
Chatzielefteriou, M
Papassotiriou, I
Kattamis, A
author_sort Delaporta, P
collection PubMed
description
format Online
Article
Text
id pubmed-8811850
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-88118502022-02-22 S124: ADVERSE EVENTS FOLLOWING COVID-19 VACCINATION IN TRANSFUSION-DEPENDENT -THALASSEMIA PATIENTS Delaporta, P Kyriakopoulou, D Ioakeimidou, N Solomou, E Binenbaum, I Toutoudaki, K Chatzielefteriou, M Papassotiriou, I Kattamis, A Hemasphere Oral Presentations Lippincott Williams & Wilkins 2022-01-31 /pmc/articles/PMC8811850/ http://dx.doi.org/10.1097/01.HS9.0000821464.52797.65 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Presentations
Delaporta, P
Kyriakopoulou, D
Ioakeimidou, N
Solomou, E
Binenbaum, I
Toutoudaki, K
Chatzielefteriou, M
Papassotiriou, I
Kattamis, A
S124: ADVERSE EVENTS FOLLOWING COVID-19 VACCINATION IN TRANSFUSION-DEPENDENT -THALASSEMIA PATIENTS
title S124: ADVERSE EVENTS FOLLOWING COVID-19 VACCINATION IN TRANSFUSION-DEPENDENT -THALASSEMIA PATIENTS
title_full S124: ADVERSE EVENTS FOLLOWING COVID-19 VACCINATION IN TRANSFUSION-DEPENDENT -THALASSEMIA PATIENTS
title_fullStr S124: ADVERSE EVENTS FOLLOWING COVID-19 VACCINATION IN TRANSFUSION-DEPENDENT -THALASSEMIA PATIENTS
title_full_unstemmed S124: ADVERSE EVENTS FOLLOWING COVID-19 VACCINATION IN TRANSFUSION-DEPENDENT -THALASSEMIA PATIENTS
title_short S124: ADVERSE EVENTS FOLLOWING COVID-19 VACCINATION IN TRANSFUSION-DEPENDENT -THALASSEMIA PATIENTS
title_sort s124: adverse events following covid-19 vaccination in transfusion-dependent -thalassemia patients
topic Oral Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811850/
http://dx.doi.org/10.1097/01.HS9.0000821464.52797.65
work_keys_str_mv AT delaportap s124adverseeventsfollowingcovid19vaccinationintransfusiondependentthalassemiapatients
AT kyriakopouloud s124adverseeventsfollowingcovid19vaccinationintransfusiondependentthalassemiapatients
AT ioakeimidoun s124adverseeventsfollowingcovid19vaccinationintransfusiondependentthalassemiapatients
AT solomoue s124adverseeventsfollowingcovid19vaccinationintransfusiondependentthalassemiapatients
AT binenbaumi s124adverseeventsfollowingcovid19vaccinationintransfusiondependentthalassemiapatients
AT toutoudakik s124adverseeventsfollowingcovid19vaccinationintransfusiondependentthalassemiapatients
AT chatzielefterioum s124adverseeventsfollowingcovid19vaccinationintransfusiondependentthalassemiapatients
AT papassotirioui s124adverseeventsfollowingcovid19vaccinationintransfusiondependentthalassemiapatients
AT kattamisa s124adverseeventsfollowingcovid19vaccinationintransfusiondependentthalassemiapatients

Ejemplares similares